Violence Against Ebola Responders Plagues Outbreak Response As Case Counts Plateau 08/11/2019 Grace Ren The number of Ebola cases per week has plateaued at a low, but consistent, count of 19 per week in the past 21 days, but the violent death of a radio journalist who had won acclaim for his Ebola outreach work has responders remaining vigilant. One Ebola case was also detected this week at a […] Continue reading -> Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> Ebola Public Health Emergency Still In Force, Despite Decline In Cases 18/10/2019 Grace Ren & Elaine Ruth Fletcher The World Health Organization is not yet ready to declare that the Ebola public health emergency in the Democratic Republic of Congo is over – despite significant recent declines in the pace of new infections. WHO Director General Dr Tedros Adhanom Ghebreyesus said Friday that he did not find it prudent to end the “Public […] Continue reading -> We’re Learning More About Gaps In Epidemic Preparedness; Now We Must Act Rapidly To Close Them 18/10/2019 Amanda McClelland and Stella Chungong In August, the Democratic Republic of the Congo (DRC) passed a milestone—surpassing 3,000 cases of Ebola since the outbreak began over a year ago. While the number of new infections has since slowed, there continue to be cases in hard to reach areas, posing challenges to response teams. The outbreak response has been complex, with […] Continue reading -> Climate Change And Unsustainable Development Can Increase Risk Of Ebola Outbreaks 16/10/2019 Editorial team The risk of future Ebola outbreaks could be greatly reduced by more aggressive climate mitigation measures along with rapid progress on the Sustainable Development Goals, according to a new paper published in Nature Communications. Led by researchers at University College London, the article is the first study to examine the potential effects of global warming […] Continue reading -> 1000th Ebola Survivor Returns Home As Operational & Security Challenges Hinder Response 04/10/2019 Grace Ren The 1000th Ebola survivor of the current outbreak in the Democratic Republic of the Congo (DRC) has just celebrated her return home. “Today, amid our unrelenting work to end this tenth outbreak of Ebola virus disease in the Democratic Republic of the Congo, we celebrate a bright spot, which is actually 1000 bright spots – […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> Ebola Public Health Emergency Still In Force, Despite Decline In Cases 18/10/2019 Grace Ren & Elaine Ruth Fletcher The World Health Organization is not yet ready to declare that the Ebola public health emergency in the Democratic Republic of Congo is over – despite significant recent declines in the pace of new infections. WHO Director General Dr Tedros Adhanom Ghebreyesus said Friday that he did not find it prudent to end the “Public […] Continue reading -> We’re Learning More About Gaps In Epidemic Preparedness; Now We Must Act Rapidly To Close Them 18/10/2019 Amanda McClelland and Stella Chungong In August, the Democratic Republic of the Congo (DRC) passed a milestone—surpassing 3,000 cases of Ebola since the outbreak began over a year ago. While the number of new infections has since slowed, there continue to be cases in hard to reach areas, posing challenges to response teams. The outbreak response has been complex, with […] Continue reading -> Climate Change And Unsustainable Development Can Increase Risk Of Ebola Outbreaks 16/10/2019 Editorial team The risk of future Ebola outbreaks could be greatly reduced by more aggressive climate mitigation measures along with rapid progress on the Sustainable Development Goals, according to a new paper published in Nature Communications. Led by researchers at University College London, the article is the first study to examine the potential effects of global warming […] Continue reading -> 1000th Ebola Survivor Returns Home As Operational & Security Challenges Hinder Response 04/10/2019 Grace Ren The 1000th Ebola survivor of the current outbreak in the Democratic Republic of the Congo (DRC) has just celebrated her return home. “Today, amid our unrelenting work to end this tenth outbreak of Ebola virus disease in the Democratic Republic of the Congo, we celebrate a bright spot, which is actually 1000 bright spots – […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Ebola Public Health Emergency Still In Force, Despite Decline In Cases 18/10/2019 Grace Ren & Elaine Ruth Fletcher The World Health Organization is not yet ready to declare that the Ebola public health emergency in the Democratic Republic of Congo is over – despite significant recent declines in the pace of new infections. WHO Director General Dr Tedros Adhanom Ghebreyesus said Friday that he did not find it prudent to end the “Public […] Continue reading -> We’re Learning More About Gaps In Epidemic Preparedness; Now We Must Act Rapidly To Close Them 18/10/2019 Amanda McClelland and Stella Chungong In August, the Democratic Republic of the Congo (DRC) passed a milestone—surpassing 3,000 cases of Ebola since the outbreak began over a year ago. While the number of new infections has since slowed, there continue to be cases in hard to reach areas, posing challenges to response teams. The outbreak response has been complex, with […] Continue reading -> Climate Change And Unsustainable Development Can Increase Risk Of Ebola Outbreaks 16/10/2019 Editorial team The risk of future Ebola outbreaks could be greatly reduced by more aggressive climate mitigation measures along with rapid progress on the Sustainable Development Goals, according to a new paper published in Nature Communications. Led by researchers at University College London, the article is the first study to examine the potential effects of global warming […] Continue reading -> 1000th Ebola Survivor Returns Home As Operational & Security Challenges Hinder Response 04/10/2019 Grace Ren The 1000th Ebola survivor of the current outbreak in the Democratic Republic of the Congo (DRC) has just celebrated her return home. “Today, amid our unrelenting work to end this tenth outbreak of Ebola virus disease in the Democratic Republic of the Congo, we celebrate a bright spot, which is actually 1000 bright spots – […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
We’re Learning More About Gaps In Epidemic Preparedness; Now We Must Act Rapidly To Close Them 18/10/2019 Amanda McClelland and Stella Chungong In August, the Democratic Republic of the Congo (DRC) passed a milestone—surpassing 3,000 cases of Ebola since the outbreak began over a year ago. While the number of new infections has since slowed, there continue to be cases in hard to reach areas, posing challenges to response teams. The outbreak response has been complex, with […] Continue reading -> Climate Change And Unsustainable Development Can Increase Risk Of Ebola Outbreaks 16/10/2019 Editorial team The risk of future Ebola outbreaks could be greatly reduced by more aggressive climate mitigation measures along with rapid progress on the Sustainable Development Goals, according to a new paper published in Nature Communications. Led by researchers at University College London, the article is the first study to examine the potential effects of global warming […] Continue reading -> 1000th Ebola Survivor Returns Home As Operational & Security Challenges Hinder Response 04/10/2019 Grace Ren The 1000th Ebola survivor of the current outbreak in the Democratic Republic of the Congo (DRC) has just celebrated her return home. “Today, amid our unrelenting work to end this tenth outbreak of Ebola virus disease in the Democratic Republic of the Congo, we celebrate a bright spot, which is actually 1000 bright spots – […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Climate Change And Unsustainable Development Can Increase Risk Of Ebola Outbreaks 16/10/2019 Editorial team The risk of future Ebola outbreaks could be greatly reduced by more aggressive climate mitigation measures along with rapid progress on the Sustainable Development Goals, according to a new paper published in Nature Communications. Led by researchers at University College London, the article is the first study to examine the potential effects of global warming […] Continue reading -> 1000th Ebola Survivor Returns Home As Operational & Security Challenges Hinder Response 04/10/2019 Grace Ren The 1000th Ebola survivor of the current outbreak in the Democratic Republic of the Congo (DRC) has just celebrated her return home. “Today, amid our unrelenting work to end this tenth outbreak of Ebola virus disease in the Democratic Republic of the Congo, we celebrate a bright spot, which is actually 1000 bright spots – […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
1000th Ebola Survivor Returns Home As Operational & Security Challenges Hinder Response 04/10/2019 Grace Ren The 1000th Ebola survivor of the current outbreak in the Democratic Republic of the Congo (DRC) has just celebrated her return home. “Today, amid our unrelenting work to end this tenth outbreak of Ebola virus disease in the Democratic Republic of the Congo, we celebrate a bright spot, which is actually 1000 bright spots – […] Continue reading -> Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Building the Back End of Health Care Finance & Access 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Kenya Rolls Out Landmark Malaria Vaccine Pilot 13/09/2019 Editorial team Kenya initiated a national pilot of the world’s first malaria vaccine today, joining Ghana and Malawi to introduce the landmark vaccine as a tool against a disease that remains a leading killer of children under the age of 5 years, particularly in Sub-Saharan Africa. The vaccine, known as RTS,S, will be rolled out nationally in […] Continue reading -> Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Independent monitoring board recommends early termination of Ebola therapeutics trial in DRC because of favorable results with two of four candidates 12/08/2019 Press release [US National Institutes of Health] 12 August, 2019 The Pamoja Tulinde Maisha (PALM [together save lives]) study is a randomized, controlled trial of four investigational agents (ZMapp, remdesivir, mAb114 and REGN-EB3) for the treatment of patients with Ebola virus disease. The study began on Nov. 20, 2018 in the Democratic Republic of the Congo (DRC) […] Continue reading -> GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
GSK Grants Exclusive Technology License For Clinical-Stage Ebola Vaccines To Sabin Vaccine Institute 09/08/2019 Press release [Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading -> Posts navigation Older postsNewer posts